• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice.患者报告结局研究在现代眼科中的应用:对临床试验和常规临床实践的影响。
Patient Relat Outcome Meas. 2019 Jan 24;10:9-24. doi: 10.2147/PROM.S162802. eCollection 2019.
2
3
Patient-Reported Outcome Measure Use in Guidelines Published by the American Academy of Ophthalmology: A Review.美国眼科学会发布的指南中患者报告结局指标的应用:一项综述
Ophthalmology. 2023 Nov;130(11):1201-1211. doi: 10.1016/j.ophtha.2023.07.001. Epub 2023 Jul 8.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Integrating Patient Reported Outcome Measures (PROMs) into routine nurse-led primary care for patients with multimorbidity: a feasibility and acceptability study.将患者报告结局测量(PROMs)整合到多病症患者常规护士主导的初级保健中:一项可行性和可接受性研究。
Health Qual Life Outcomes. 2021 Apr 26;19(1):133. doi: 10.1186/s12955-021-01748-2.
6
Measuring Quality of Life in Diabetic Retinal Disease: A Narrative Review of Available Patient-Reported Outcome Measures.糖尿病视网膜病变患者生活质量的测量:对现有患者报告结局指标的叙述性综述
Ophthalmol Sci. 2023 Aug 9;4(2):100378. doi: 10.1016/j.xops.2023.100378. eCollection 2024 Mar-Apr.
7
An introduction to patient-reported outcome measures in ophthalmic research.眼科研究中患者报告结局指标介绍
Eye (Lond). 2014 Jun;28(6):637-45. doi: 10.1038/eye.2014.41. Epub 2014 Mar 14.
8
Are Patient Self-Reported Outcome Measures Sensitive Enough to Be Used as End Points in Clinical Trials?: Evidence from the United Kingdom Glaucoma Treatment Study.患者自评结果测量指标是否足够敏感,可作为临床试验的终点?来自英国青光眼治疗研究的证据。
Ophthalmology. 2019 May;126(5):682-689. doi: 10.1016/j.ophtha.2018.09.034. Epub 2018 Sep 28.
9
Surgeon Perceptions of the Integration of Patient-Reported Outcome Measures into Clinical Practice.外科医生对患者报告的结局测量指标融入临床实践的看法。
J Surg Res. 2022 Dec;280:486-494. doi: 10.1016/j.jss.2022.07.038. Epub 2022 Sep 3.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

引用本文的文献

1
Functional and Emotional Impact of Dry Eye and Meibomian Gland Dysfunction in Keratoconus.圆锥角膜中干眼和睑板腺功能障碍的功能及情感影响
Biomedicines. 2025 Aug 6;13(8):1918. doi: 10.3390/biomedicines13081918.
2
Patient experience in retinitis pigmentosa and Choroideremia- a concept elicitation study in 17 patients based on qualitative interviews.色素性视网膜炎和脉络膜视网膜病变患者的体验——基于定性访谈对17名患者的概念激发研究
Orphanet J Rare Dis. 2025 Aug 11;20(1):418. doi: 10.1186/s13023-025-03713-4.
3
Clinical research on the application of AI-assisted computing systems in the treatment of intermittent exotropia.人工智能辅助计算系统在间歇性外斜视治疗中的应用临床研究
BMC Ophthalmol. 2025 Jul 28;25(1):432. doi: 10.1186/s12886-025-04240-3.
4
Understanding Glaucoma: Why it Remains a Leading Cause of Blindness Worldwide.了解青光眼:为何它仍是全球失明的主要原因。
Klin Monbl Augenheilkd. 2025 Jul;242(7):712-717. doi: 10.1055/a-2617-1575. Epub 2025 Jul 24.
5
The Effects of Outdoor Activity on Patient-Reported Visual Outcomes Under Perioperative Management Using Cyclosporine and Rebamipide.围手术期使用环孢素和瑞巴派特管理下户外活动对患者报告的视觉结果的影响。
Diagnostics (Basel). 2025 Jun 26;15(13):1629. doi: 10.3390/diagnostics15131629.
6
Validation of the Italian Version of the Visual Function and Corneal Health Status (V-FUCHS) Questionnaire: A Patient-Reported Visual Disability Instrument for Fuchs' Endothelial Corneal Dystrophy.视觉功能与角膜健康状况(V-FUCHS)问卷意大利语版本的验证:一种用于富克斯内皮角膜营养不良的患者报告视觉残疾工具。
J Clin Med. 2025 Jun 5;14(11):3996. doi: 10.3390/jcm14113996.
7
Defining and measuring acceptability of surgical interventions: A scoping review.定义和衡量外科手术干预的可接受性:一项范围综述。
PLoS One. 2025 Jun 3;20(6):e0323738. doi: 10.1371/journal.pone.0323738. eCollection 2025.
8
Translation, cross-cultural adaptation, and validation of the Norwegian version of the Keratoconus Outcomes Research Questionnaire.圆锥角膜结局研究问卷挪威语版本的翻译、跨文化调适及验证
J Patient Rep Outcomes. 2025 May 22;9(1):57. doi: 10.1186/s41687-025-00896-z.
9
English version of the Computer Vision Symptom Scale (CVSS17): Translation and Rasch analysis-based cultural adaptation.计算机视觉症状量表(CVSS17)英文版:基于翻译和拉施分析的文化调适
PLoS One. 2025 Apr 16;20(4):e0316936. doi: 10.1371/journal.pone.0316936. eCollection 2025.
10
Emerging perspectives in quality of life after trabeculectomy surgery.小梁切除术后生活质量的新观点
Eye (Lond). 2025 May;39(7):1394-1399. doi: 10.1038/s41433-025-03636-1. Epub 2025 Feb 8.

本文引用的文献

1
Patient-derived questionnaire items for patient-reported outcome measures in pediatric eye conditions.用于小儿眼科疾病患者报告结局测量的患者源性问卷项目。
J AAPOS. 2018 Dec;22(6):445-448.e22. doi: 10.1016/j.jaapos.2018.05.020. Epub 2018 Sep 21.
2
The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data.青光眼强化治疗研究(GITS),一项随机临床试验:设计、方法学和基线数据。
Acta Ophthalmol. 2018 Sep;96(6):557-566. doi: 10.1111/aos.13791. Epub 2018 Aug 31.
3
MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration.MACUSTAR:中年相关性黄斑变性功能性、结构性及患者报告终点的开发与临床验证
Ophthalmologica. 2019;241(2):61-72. doi: 10.1159/000491402. Epub 2018 Aug 28.
4
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials.朝着使癌症随机临床试验中生活质量数据分析标准化的方向前进。
Clin Trials. 2018 Dec;15(6):624-630. doi: 10.1177/1740774518795637. Epub 2018 Aug 24.
5
Usage of glaucoma-specific patient-reported outcome measures (PROMs) in the Singapore context: a qualitative scoping exercise.青光眼特异性患者报告结局量表(PROMs)在新加坡背景下的应用:一项定性范围界定研究。
BMC Ophthalmol. 2018 Aug 14;18(1):197. doi: 10.1186/s12886-018-0803-5.
6
Constructing Item Banks for Measuring Quality of Life in Refractive Error.构建用于测量屈光不正患者生活质量的题库。
Optom Vis Sci. 2018 Jul;95(7):575-587. doi: 10.1097/OPX.0000000000001246.
7
Exploring the quality of life issues in people with retinal diseases: a qualitative study.探索视网膜疾病患者的生活质量问题:一项定性研究。
J Patient Rep Outcomes. 2017;1(1):15. doi: 10.1186/s41687-017-0023-4. Epub 2017 Sep 21.
8
A Systematic Review of Patient-Reported Outcomes for Surgically Amenable Epiphora.手术可治疗性泪溢患者报告结局的系统评价
Ophthalmic Plast Reconstr Surg. 2018 May/Jun;34(3):193-200. doi: 10.1097/IOP.0000000000000977.
9
Developing an item bank to measure the coping strategies of people with hereditary retinal diseases.开发一个用于衡量遗传性视网膜疾病患者应对策略的题库。
Graefes Arch Clin Exp Ophthalmol. 2018 Jul;256(7):1291-1298. doi: 10.1007/s00417-018-3998-5. Epub 2018 May 5.
10
Patient reported outcome measures in rare diseases: a narrative review.罕见病患者报告结局测量指标:叙事性综述。
Orphanet J Rare Dis. 2018 Apr 23;13(1):61. doi: 10.1186/s13023-018-0810-x.

患者报告结局研究在现代眼科中的应用:对临床试验和常规临床实践的影响。

The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice.

作者信息

Braithwaite Tasanee, Calvert Melanie, Gray Alastair, Pesudovs Konrad, Denniston Alastair K

机构信息

Centre for Patient Reported Outcomes Research and NIHR Birmingham Biomedical Research Centre, University of Birmingham, Edgbaston, Birmingham, UK,

Moorfields Eye Hospital, London, UK,

出版信息

Patient Relat Outcome Meas. 2019 Jan 24;10:9-24. doi: 10.2147/PROM.S162802. eCollection 2019.

DOI:10.2147/PROM.S162802
PMID:30774489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6352858/
Abstract

This review article considers the rising demand for patient-reported outcome measures (PROMs) in modern ophthalmic research and clinical practice. We review what PROMs are, how they are developed and chosen for use, and how their quality can be critically appraised. We outline the progress made to develop PROMs in each clinical subspecialty. We highlight recent examples of the use of PROMs as secondary outcome measures in randomized controlled clinical trials and consider the impact they have had. With increasing interest in using PROMs as primary outcome measures, particularly where interventions have been found to be of equivalent efficacy by traditional outcome metrics, we highlight the importance of instrument precision in permitting smaller sample sizes to be recruited. Our review finds that while there has been considerable progress in PROM development, particularly in cataract, glaucoma, medical retina, and low vision, there is a paucity of useful tools for less common ophthalmic conditions. Development and validation of item banks, administered using computer adaptive testing, has been proposed as a solution to overcome many of the traditional limitations of PROMs, but further work will be needed to examine their acceptability to patients, clinicians, and investigators.

摘要

这篇综述文章探讨了现代眼科研究和临床实践中对患者报告结局测量指标(PROMs)需求不断上升的情况。我们回顾了PROMs是什么,它们是如何开发和选择使用的,以及如何对其质量进行严格评估。我们概述了在每个临床亚专业中开发PROMs所取得的进展。我们重点介绍了PROMs在随机对照临床试验中作为次要结局指标使用的最新实例,并考虑了它们所产生的影响。随着越来越多的人关注将PROMs用作主要结局指标,特别是在传统结局指标发现干预措施具有同等疗效的情况下,我们强调了仪器精度在允许招募更小样本量方面的重要性。我们的综述发现,虽然在PROMs开发方面取得了相当大的进展,特别是在白内障、青光眼、视网膜内科和低视力领域,但对于不太常见的眼科疾病,有用的工具却很匮乏。有人提议开发和验证使用计算机自适应测试进行管理的题库,作为克服PROMs许多传统局限性的一种解决方案,但还需要进一步开展工作来检验患者、临床医生和研究人员对它们的接受程度。